The Veteran's tinea versicolor was initially rated at 10 percent prior to May 30, 2017 and in excess of 10 percent thereafter. The Board found that the criteria for an initial compensable rating were not met before May 30, 2017, and that on or after May 30, 2017, the criteria for a rating in excess of 10 percent were not met.
The deciding factor: The Veteran's tinea versicolor did not manifest as lesions involving at least 5 percent of the entire body or 5 percent of exposed skin; or require use of any systemic therapy before May 30, 2017. After May 30, 2017, it manifested as lesions involving less than 20 percent of the entire body and required no use of any systemic therapy.
- Claimed conditions
- tinea versicolor
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 10%
- Decision date
- October 20, 2022
- Citation
- 22058995
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 22058995.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board is remanding the claim for tinea versicolor to ensure that VA fulfills its duty to assist by obtaining private medical records and potentially scheduling a new examination.
- Granted
The Board granted service connection for enlarged liver (fatty infiltration), benign prostate hypertrophy, and tinea versicolor as secondary to the Veteran's service-connected diabetes mellitus, type II.
- Partly granted
The Board granted readjudication for the claims of service connection for left foot hallux valgus and tinea versicolor, but denied the claims for tinea corporis, tinea cruris, carbuncle, cyst, and scarring secondary to tinea versicolor.
- Partly granted
The Board granted a 10 percent disability rating for dermatitis, variously diagnosed as seborrheic dermatitis, dermatophytosis, and tinea versicolor, prior to June 5, 2023, but denied a higher rating from that date. The issues related to Raynaud's syndrome and special monthly compensation were remanded.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.